Ginkgo biloba extract for improving cognitive impairment as well as preparation method and application of ginkgo biloba extract
By using eutectic solvents and resin purification technology, high content of ginkgo leaf extract was prepared, which solved the problem of major side effects of existing drugs, achieved efficient and environmentally friendly cognitive impairment improvement effect, and was suitable for industrial production.
Patent Information
- Application Number
- CN202411173826.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-26
AI Technical Summary
The existing drugs used to improve memory and mild cognitive dysfunction on the market have great toxic side effects and lack effective environmentally friendly and high-component ginkgo leaf extracts suitable for industrial production.
Using eutectic solvents (a mixture of L-carnitine, urea and trifluoromethanesulfonic acid) and ultrasonic and resin purification technology, a high content of total flavonol glycosides and total Ginkgo leaf extract of terpenoids and proanthocyanins.
It significantly improves the retention rate and separation efficiency of pharmacological active ingredients, reduces production costs, is suitable for industrial production, and significantly improves cognitive impairment conditions.
Smart Images

Figure BDA0005010130580000071 
Figure BDA0005010130580000081
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medicine, and in particular relates to a ginkgo leaf extract for improving cognitive impairment, a preparation method and an application thereof. Background Art
[0002] Ginkgo biloba is a plant of the Ginkgoaceae family, and its leaves and fruits have important medicinal value. Ginkgo biloba extract is a mixture extracted from ginkgo biloba leaves with unique pharmacological activity. Many scholars at home and abroad have used modern separation technology and testing methods to study the chemical composition of ginkgo biloba extract, and found more than 100 chemical components including flavonoids, terpenoid lactones, polyisoprenols, organic acids, alkylphenols and alkylphenolic acids, steroid compounds, amino acids and trace elements in ginkgo biloba extract. Ginkgo biloba extract has a very strong antioxidant effect, which can remove excess free radicals in the body, prevent lipid peroxidation in the body, improve the body's immunity, and delay aging.
[0003] Chinese invention patent application 201610149596.0 discloses a preparation process of a water-soluble ginkgo leaf extract and a water-soluble ginkgo leaf extract. The preparation process of the water-soluble ginkgo leaf extract of the invention is characterized in that the process uses a fat-soluble ginkgo leaf extract as a raw material and 22-28% hot ethanol as an extraction solvent. The process is efficient, safe, simple and economical. The obtained water-soluble extract is 100% soluble in water, and its total brass content of the active ingredient is 24-27%, the internal fat content is 6-8%, and the ginkgolic acid content is less than 5 parts per million (5ppm). The oral solution prepared with it is pure, transparent, free of precipitation and suspended matter, and is also easily absorbed by human tissues, and its bioavailability is at least 20% higher than that of ordinary solid preparations.
[0004] Another Chinese invention patent application 201711095244.2 discloses a method for preparing ginkgo leaf extract, which uses ethanol-water solution as the extraction solvent, performs three cycles of extraction and collects the remaining alcohol solution by distillation, and during the intervals between the three alcohol extractions, appropriately irradiates the ginkgo leaves with microwaves, which can cause the cells in the effective parts inside the leaves to preheat and swell, so that these cells will break first during the alcohol extraction, and the effective substances will be precipitated more fully; then, two-stage concentration is used, followed by water precipitation and purification, and then separation and deacidification through a resin column and then concentration and drying can be performed to obtain a ginkgo leaf extract with the total ginkgolic acid as the harmful component removed and the purity of the total flavonol glycosides and terpenoid lactones increased; the resin column is used as the adsorbent and the ethanol-water solution is used as the eluent; the beneficial effects are low cost, good separation effect, removal of harmful components, high yield, less pollution, good quality, and easy industrial production.
[0005] Modern medical research shows that the pathogenesis of memory and mild cognitive impairment is extremely complex, involving multiple gene defects, environmental influences, neurotoxins, cell apoptosis, oxidative stress, β-AP (β-amyloid protein) aggregation, inflammatory response, Ca2+ There are many aspects and aspects such as overload and cholinergic and other multi-system degeneration. There is no special effective drug for the symptoms of memory and mild cognitive dysfunction. At present, the main drugs used on the market to improve Alzheimer's disease are cholinesterase inhibitors, glutamate receptor antagonists, calcium ion antagonists and estrogen, etc. The above drugs are mainly chemical drugs with large toxic side effects.
[0006] Therefore, there is an urgent need to provide a ginkgo leaf extract that has a high content of active ingredients, is environmentally friendly and suitable for industrial production and is used to improve cognitive impairment. Summary of the invention
[0007] In view of the problems existing in the prior art, the present invention provides a ginkgo leaf extract for improving cognitive impairment, a preparation method thereof and an application thereof.
[0008] A method for preparing a ginkgo leaf extract for improving cognitive impairment comprises the following steps:
[0009] (1) First, crush the ginkgo leaves and sieve them to obtain ginkgo leaf powder;
[0010] (2) mixing the ginkgo leaf powder with a low eutectic solvent, extracting, and obtaining an extract;
[0011] (3) Finally, the extract is sequentially adsorbed by a macroporous resin and a polyamide column, and the eluate is collected to obtain:
[0012] The low eutectic solvent is a mixture of L-carnitine, urea and trifluoromethanesulfonic acid in a molar ratio of 1.5-2:1:0.2-0.4.
[0013] Preferably, the deep eutectic solvent is a mixture of L-carnitine, urea and trifluoromethanesulfonic acid in a molar ratio of 2:1:0.2.
[0014] Preferably, the mesh size of the sieving in step (1) is 60-80 meshes.
[0015] Preferably, the water content of the deep eutectic solvent is 30-40%.
[0016] Preferably, the mass volume ratio of the ginkgo leaf powder to the solvent in step (2) is 1 g:20-30 mL.
[0017] Preferably, the mixing in step (2) requires ultrasound, the ultrasound temperature is 30-40° C., the ultrasound power is 80-100 W, the ultrasound time is 20-30 min, and centrifugation and filtration are performed after the ultrasound is completed.
[0018] Preferably, the macroporous resin in step (3) is DM-130, and the adsorption comprises adsorbing the extract through the DM-130 macroporous resin, first eluting with water to neutrality, then eluting with 10-20 times the column volume and a volume fraction of 75-85% ethanol solution, collecting the eluate, and concentrating under reduced pressure to obtain a concentrated solution; then passing the concentrated solution through a polyamide column, first eluting with 8-10 times the column volume and a volume fraction of 20-30% ethanol solution, and then eluting with 8-10 times the column volume and a volume fraction of 40-50% ethanol solution.
[0019] Preferably, the elution flow rate is 1-5 BV / h, and the elution temperature is 15-35°C.
[0020] Preferably, after the eluate is collected in step (3), the eluate is concentrated and dried, and the drying is performed by vacuum drying, freeze drying or spray drying to a moisture content of 10-15%.
[0021] The present invention also provides a ginkgo leaf extract prepared by the above preparation method, wherein the effective components of the ginkgo leaf extract include total flavonol glycosides, total terpenoid lactones and proanthocyanidins, and the content ratio of the total flavonol glycosides, total terpenoid lactones and proanthocyanidins is 10-11:3-4:2-3.
[0022] The present invention also provides a pharmaceutical composition for improving cognitive impairment, comprising the above-mentioned ginkgo leaf extract or the ginkgo leaf extract prepared by the above-mentioned preparation method.
[0023] The present invention also provides the use of the ginkgo leaf extract or the ginkgo leaf extract prepared by the above preparation method or the above pharmaceutical composition in the preparation of health products or medicines for preventing / treating and improving cognitive impairment.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] (1) The present invention uses a specific low eutectic solvent in the preparation process of the ginkgo leaf extract, and retains the pharmacological activity and the content of the effective ingredients total flavonol glycosides, total terpenoid lactones and proanthocyanidins to the greatest extent through the synergistic effect of L-carnitine, urea and trifluoromethanesulfonic acid.
[0026] (2) The present invention uses a specific resin purification process in the preparation of the ginkgo leaf extract, which makes the separation efficiency of the effective ingredients high, the separation speed fast, and the experimental cycle shortened.
[0027] (3) The preparation method of the ginkgo leaf extract provided by the present invention includes ultrasonic dissolution and resin purification, has low requirements for instruments and equipment, low cost, and is suitable for industrial production.
[0028] (4) The present invention provides a ginkgo leaf extract for improving cognitive impairment. The content ratio of total flavonol glycosides, total terpenoid lactones and proanthocyanidins in the extract is 10-11:3-4:2-3, which can significantly improve cognitive impairment symptoms. DETAILED DESCRIPTION
[0029] It is worth noting that the raw materials used in the present invention are all common commercially available products.
[0030] Example 1
[0031] A method for preparing a ginkgo leaf extract for improving cognitive impairment, comprising the following steps:
[0032] (1) Grinding the ginkgo leaves and passing through an 80-mesh sieve to obtain ginkgo leaf powder;
[0033] (2) 5 g of ginkgo leaf powder was ultrasonically mixed with 125 mL of a low eutectic solvent having a water content of 40% (the low eutectic solvent was a mixture of L-carnitine, urea and trifluoromethanesulfonic acid in a molar ratio of 2:1:0.2), the ultrasonic temperature was set to 40° C., the ultrasonic time was set to 25 min, the ultrasonic power was set to 100 W, and then the mixture was centrifuged at 2000 rpm for 15 min and filtered to obtain a ginkgo leaf extract;
[0034] (3) The ginkgo extract is then adsorbed on a DM-130 macroporous resin, first eluted with water to neutrality, then eluted with 15 times the column volume and 80% ethanol solution at a flow rate of 3 BV / h, the eluate is collected, and concentrated under reduced pressure to obtain a concentrate; the concentrate is then passed through a polyamide column, first eluted with 10 times the column volume and 25% ethanol solution at a flow rate of 5 BV / h, then eluted with 10 times the column volume and 45% ethanol solution at a flow rate of 2 BV / h, concentrated, and freeze-dried to a moisture content of 10%, thereby obtaining the ginkgo leaf extract.
[0035] Example 2
[0036] A method for preparing a ginkgo leaf extract for improving cognitive impairment comprises the following steps:
[0037] (1) Grinding the ginkgo leaves and passing through an 80-mesh sieve to obtain ginkgo leaf powder;
[0038] (2) 5 g of ginkgo leaf powder was ultrasonically mixed with 100 mL of a low eutectic solvent having a water content of 30% (the low eutectic solvent was a mixture of L-carnitine, urea and trifluoromethanesulfonic acid in a molar ratio of 1.5:1:0.4), the ultrasonic temperature was set to 30° C., the ultrasonic time was set to 20 min, the ultrasonic power was set to 80 W, and then the mixture was centrifuged at 2000 rpm for 15 min and filtered to obtain a ginkgo leaf extract;
[0039] (3) The ginkgo extract is then adsorbed on a DM-130 macroporous resin, first eluted with water to neutrality, then eluted with 10 times the column volume and 75% ethanol solution at a flow rate of 4 BV / h, the eluate is collected, and concentrated under reduced pressure to obtain a concentrate; the concentrate is then passed through a polyamide column, first eluted with 8 times the column volume and 25% ethanol solution at a flow rate of 5 BV / h, then eluted with 8 times the column volume and 45% ethanol solution at a flow rate of 1 BV / h, concentrated, and freeze-dried to a water content of 12%, thereby obtaining the ginkgo leaf extract.
[0040] Example 3
[0041] A method for preparing a ginkgo leaf extract for improving cognitive impairment comprises the following steps:
[0042] (1) Grinding the ginkgo leaves and passing through a 60-mesh sieve to obtain ginkgo leaf powder;
[0043] (2) 5 g of ginkgo leaf powder was ultrasonically mixed with 150 mL of a low eutectic solvent having a water content of 40% (the low eutectic solvent was a mixture of L-carnitine, urea and trifluoromethanesulfonic acid in a molar ratio of 2:1:0.2), the ultrasonic temperature was set to 40° C., the ultrasonic time was set to 30 min, the ultrasonic power was set to 100 W, and then the mixture was centrifuged at 2000 rpm for 20 min and filtered to obtain a ginkgo leaf extract;
[0044] (3) The ginkgo extract is then adsorbed on a DM-130 macroporous resin, first eluted with water to neutrality, then eluted with 20 times the column volume and 85% ethanol solution at a flow rate of 3 BV / h, the eluate is collected, and concentrated under reduced pressure to obtain a concentrate; the concentrate is then passed through a polyamide column, first eluted with 10 times the column volume and 25% ethanol solution at a flow rate of 5 BV / h, then eluted with 10 times the column volume and 45% ethanol solution at a flow rate of 2 BV / h, concentrated, and freeze-dried to a water content of 15%, thereby obtaining the ginkgo leaf extract.
[0045] Comparative Example 1
[0046] A method for preparing a ginkgo leaf extract for improving cognitive impairment, which is different from Example 1 only in that the low eutectic solvent in step (2) is a mixture of urea and trifluoromethanesulfonic acid in a molar ratio of 1:0.2.
[0047] A method for preparing a ginkgo leaf extract for improving cognitive impairment comprises the following steps:
[0048] (1) Grinding the ginkgo leaves and passing through an 80-mesh sieve to obtain ginkgo leaf powder;
[0049] (2) 5 g of ginkgo leaf powder was ultrasonically mixed with 125 mL of a low eutectic solvent having a water content of 40% (the low eutectic solvent was a mixture of urea and trifluoromethanesulfonic acid in a molar ratio of 1:0.2), the ultrasonic temperature was set to 40° C., the ultrasonic time was set to 25 min, the ultrasonic power was set to 100 W, and then the mixture was centrifuged at 2000 rpm for 15 min and filtered to obtain a ginkgo leaf extract;
[0050] (3) The ginkgo extract is then adsorbed on a DM-130 macroporous resin, first eluted with water to neutrality, then eluted with 15 times the column volume and 80% ethanol solution at a flow rate of 3 BV / h, the eluate is collected, and concentrated under reduced pressure to obtain a concentrate; the concentrate is then passed through a polyamide column, first eluted with 10 times the column volume and 25% ethanol solution at a flow rate of 5 BV / h, then eluted with 10 times the column volume and 45% ethanol solution at a flow rate of 2 BV / h, concentrated, and freeze-dried to a moisture content of 10%, thereby obtaining the ginkgo leaf extract.
[0051] Comparative Example 2
[0052] A method for preparing a ginkgo leaf extract for improving cognitive impairment, which is different from Example 1 only in that the low eutectic solvent in step (2) is a mixture of L-carnitine and trifluoromethanesulfonic acid in a molar ratio of 2:0.2.
[0053] A method for preparing a ginkgo leaf extract for improving cognitive impairment comprises the following steps:
[0054] (1) Grinding the ginkgo leaves and passing through an 80-mesh sieve to obtain ginkgo leaf powder;
[0055] (2) 5 g of ginkgo leaf powder was ultrasonically mixed with 125 mL of a low eutectic solvent having a water content of 40% (the low eutectic solvent was a mixture of L-carnitine and trifluoromethanesulfonic acid in a molar ratio of 2:0.2), the ultrasonic temperature was set to 40° C., the ultrasonic time was set to 25 min, the ultrasonic power was set to 100 W, and then the mixture was centrifuged at 2000 rpm for 15 min and filtered to obtain a ginkgo leaf extract;
[0056] (3) The ginkgo extract is then adsorbed on a DM-130 macroporous resin, first eluted with water to neutrality, then eluted with 15 times the column volume and 80% ethanol solution at a flow rate of 3 BV / h, the eluate is collected, and concentrated under reduced pressure to obtain a concentrate; the concentrate is then passed through a polyamide column, first eluted with 10 times the column volume and 25% ethanol solution at a flow rate of 5 BV / h, then eluted with 10 times the column volume and 45% ethanol solution at a flow rate of 2 BV / h, concentrated, and freeze-dried to a moisture content of 10%, thereby obtaining the ginkgo leaf extract.
[0057] Comparative Example 3
[0058] A method for preparing a ginkgo leaf extract for improving cognitive impairment, which is different from Example 1 only in that the low eutectic solvent in step (2) is a mixture of L-carnitine and urea in a molar ratio of 2:1.
[0059] A method for preparing a ginkgo leaf extract for improving cognitive impairment comprises the following steps:
[0060] (1) Grinding the ginkgo leaves and passing through an 80-mesh sieve to obtain ginkgo leaf powder;
[0061] (2) 5 g of ginkgo leaf powder was ultrasonically mixed with 125 mL of a low eutectic solvent having a water content of 40% (the low eutectic solvent was a mixture of L-carnitine and urea in a molar ratio of 2:1), the ultrasonic temperature was set to 40° C., the ultrasonic time was set to 25 min, the ultrasonic power was set to 100 W, and then the mixture was centrifuged at 2000 rpm for 15 min and filtered to obtain a ginkgo leaf extract;
[0062] (3) The ginkgo extract is then adsorbed on a DM-130 macroporous resin, first eluted with water to neutrality, then eluted with 15 times the column volume and 80% ethanol solution at a flow rate of 3 BV / h, the eluate is collected, and concentrated under reduced pressure to obtain a concentrate; the concentrate is then passed through a polyamide column, first eluted with 10 times the column volume and 25% ethanol solution at a flow rate of 5 BV / h, then eluted with 10 times the column volume and 45% ethanol solution at a flow rate of 2 BV / h, concentrated, and freeze-dried to a moisture content of 10%, thereby obtaining the ginkgo leaf extract.
[0063] Comparative Example 4
[0064] A method for preparing a ginkgo leaf extract for improving cognitive impairment, which is different from Example 1 only in that ultrasound is not performed in step (2).
[0065] A method for preparing a ginkgo leaf extract for improving cognitive impairment comprises the following steps:
[0066] (1) Grinding the ginkgo leaves and passing through an 80-mesh sieve to obtain ginkgo leaf powder;
[0067] (2) 5 g of ginkgo leaf powder was mixed with 125 mL of a low eutectic solvent having a water content of 40% (the low eutectic solvent was a mixture of L-carnitine, urea and trifluoromethanesulfonic acid in a molar ratio of 2:1:0.2), and then centrifuged at 2000 rpm for 15 min and filtered to obtain a ginkgo leaf extract;
[0068] (3) The ginkgo extract is then adsorbed on a DM-130 macroporous resin, first eluted with water to neutrality, then eluted with 15 times the column volume and 80% ethanol solution at a flow rate of 3 BV / h, the eluate is collected, and concentrated under reduced pressure to obtain a concentrate; the concentrate is then passed through a polyamide column, first eluted with 10 times the column volume and 25% ethanol solution at a flow rate of 5 BV / h, then eluted with 10 times the column volume and 45% ethanol solution at a flow rate of 2 BV / h, concentrated, and freeze-dried to a moisture content of 10%, thereby obtaining the ginkgo leaf extract.
[0069] Comparative Example 5
[0070] A method for preparing a ginkgo leaf extract for improving cognitive impairment, which is different from Example 1 only in that in step (3), the DM-130 macroporous resin is replaced by HP-20 macroporous resin.
[0071] A method for preparing a ginkgo leaf extract for improving cognitive impairment comprises the following steps:
[0072] (1) Grinding the ginkgo leaves and passing through an 80-mesh sieve to obtain ginkgo leaf powder;
[0073] (2) 5 g of ginkgo leaf powder was ultrasonically mixed with 125 mL of a low eutectic solvent having a water content of 40% (the low eutectic solvent was a mixture of L-carnitine, urea and trifluoromethanesulfonic acid in a molar ratio of 2:1:0.2), the ultrasonic temperature was set to 40° C., the ultrasonic time was set to 25 min, the ultrasonic power was set to 100 W, and then the mixture was centrifuged at 2000 rpm for 15 min and filtered to obtain a ginkgo leaf extract;
[0074] (3) The ginkgo extract is then adsorbed on an HP-20 macroporous resin, first eluted with water to neutrality, then eluted with 15 times the column volume and 80% ethanol solution at a flow rate of 3 BV / h, the eluate is collected, and concentrated under reduced pressure to obtain a concentrate; the concentrate is then passed through a polyamide column, first eluted with 10 times the column volume and 25% ethanol solution at a flow rate of 5 BV / h, then eluted with 10 times the column volume and 45% ethanol solution at a flow rate of 2 BV / h, concentrated, and freeze-dried to a moisture content of 10%, thereby obtaining the ginkgo leaf extract.
[0075] Content determination
[0076] According to the content determination method of Ginkgo Leaf Extract in the 2020 edition of the "Chinese Pharmacopoeia", the contents of total flavonol glycosides, total terpenoid lactones and proanthocyanidins in the ginkgo leaf extracts prepared in Examples 1-3 and Comparative Examples 1-5 were determined to obtain the content ratio of the three. The results are shown in Table 1 below.
[0077] Table 1 Determination of total flavonol glycosides, total terpenoid lactones and proanthocyanidins in Ginkgo biloba extract
[0078]
[0079] Experiment 1: Improvement effect of the ginkgo leaf extract of the present invention on Alzheimer's disease model mice
[0080] 1. Test samples: Ginkgo biloba extracts prepared in Examples 1-3 of the present invention and Comparative Examples 1-5.
[0081] 2. Experimental animals: APP / PS1 transgenic mice, SPF male, 6 months old, weighing 20±2 g, were purchased from Guangdong Medical Experimental Animal Center. They were allowed to drink water and eat freely. The room temperature was maintained at 24±2°C and the relative humidity was 55-65%.
[0082] 3. Grouping: The mice were randomly divided into 10 groups, namely, the control group, Example 1 (low, medium and high dose groups), Examples 2-3 and Comparative Examples 1-5 groups, with 10 mice in each group. The Example 1-3 and Comparative Examples 1-5 groups were gavaged with the corresponding products, and the control group was gavaged with an equal amount of physiological saline. The dosage was shown in Table 2. The mice were gavaged twice, with an interval of 2 hours, for 7 consecutive days.
[0083] 4. Experimental method: After each group of mice was given the drug, the experiment began. Each group of mice was placed in a box to adapt to the environment for 30 minutes, and then 36V AC was applied. After being shocked, the mice jumped onto the rubber platform to avoid harmful stimulation. If the mice jumped off the platform, they would return to the platform after being stimulated. After training for 5 minutes, the mice could form a memory and stay on the platform. After 24 hours of training, the test was conducted. The mice were first placed on the platform, and the latency of the mice jumping off the platform for the first time and the number of times they jumped off the platform within 5 minutes after being shocked (i.e., the number of errors) were recorded.
[0084] 5. Experimental results: As shown in Table 2, compared with the control group, the number of errors in the low-dose group of Ginkgo biloba extract in Example 1 was reduced (P<0.05), the number of errors in the high and medium-dose groups of Ginkgo biloba extract was significantly reduced (P<0.01), and the latency period of the high, medium and low-dose groups was significantly prolonged (P<0.01).
[0085] Compared with comparative examples 1-5, at the same dosage, the number of errors in Examples 1-3 was significantly lower than that in the comparative example group, and the latency was significantly longer than that in the comparative example group, indicating that the ginkgo leaf extract prepared by the present invention can consolidate the memory of mice in the passive avoidance experiment and enhance the learning ability of mice.
[0086] Table 2 Effects of Ginkgo biloba extract on learning and memory in mice
[0087]
[0088]
[0089] Note:* Compared with the control group, P < 0.05, ** Compared with the control group, P < 0.01.
[0090] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, rather than to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions of the technical solution of the present invention by ordinary technicians in this field do not deviate from the essence and scope of the technical solution of the present invention.
Claims
1. A method for preparing a ginkgo leaf extract for improving cognitive impairment, characterized in that: The following steps are involved: (1) First, crush the ginkgo leaves and sieve them to obtain ginkgo leaf powder; (2) mixing the ginkgo leaf powder with a low eutectic solvent, extracting to obtain an extract; (3) Finally, the extract is sequentially adsorbed by a macroporous resin and a polyamide column, and the eluate is collected to obtain: The low eutectic solvent is a mixture of L-carnitine, urea and trifluoromethanesulfonic acid in a molar ratio of 1.5-2:1:0.2-0.
4.
2. The preparation method according to claim 1, characterized in that: The mesh size of the sieving in step (1) is 60-80 meshes.
3. The preparation method according to claim 1, characterized in that: The water content of the deep eutectic solvent is 30-40%.
4. The preparation method according to claim 3, characterized in that: The mass volume ratio of the ginkgo leaf powder to the solvent in step (2) is 1 g:20-30 mL.
5. The preparation method according to claim 1, characterized in that: The mixing in step (2) requires ultrasound, the ultrasound temperature is 30-40°C, the ultrasound power is 80-100W, the ultrasound time is 20-30min, and centrifugation and filtration are performed after the ultrasound is completed.
6. The preparation method according to claim 5, characterized in that: The macroporous resin in step (3) is DM-130, and the adsorption comprises adsorbing the extract through the DM-130 macroporous resin, first eluting with water to neutrality, then eluting with 10-20 times the column volume and a volume fraction of 75-85% ethanol solution, collecting the eluate, and concentrating under reduced pressure to obtain a concentrated solution; then passing the concentrated solution through a polyamide column, first eluting with 8-10 times the column volume and a volume fraction of 20-30% ethanol solution, and then eluting with 8-10 times the column volume and a volume fraction of 40-50% ethanol solution, the elution flow rate is 1-5BV / h, and the elution temperature is 15-35°C.
7. The preparation method according to claim 1, characterized in that: After the eluate is collected in step (3), the eluate needs to be concentrated and dried. The drying may be vacuum drying, freeze drying or spray drying, and the drying may be performed to a moisture content of 10-15%.
8. A ginkgo leaf extract prepared by the preparation method according to any one of claims 1 to 7, characterized in that: The effective components of the ginkgo leaf extract include total flavonol glycosides, total terpenoid lactones and proanthocyanidins, and the content ratio of the total flavonol glycosides, total terpenoid lactones and proanthocyanidins is 10-11:3-4:2-3.
9. A pharmaceutical composition for improving cognitive impairment, characterized in that: The invention comprises the ginkgo leaf extract prepared by the preparation method according to any one of claims 1 to 7 or the ginkgo leaf extract according to claim 8.
10. Use of the ginkgo leaf extract prepared by the preparation method according to any one of claims 1 to 7, the ginkgo leaf extract according to claim 8, or the pharmaceutical composition according to claim 9 in the preparation of a health product or medicine for preventing / treating cognitive impairment.
Citation Information
Patent Citations
Preparation process of ginkgo biloba extract and water-soluble ginkgo biloba extract
CN105687263A
Method for preparing ginkgo leaf extract
CN107753529A
Pharmaceutical composition of snakegourd fruit and folium ginkgo
CN101152233A
Process for extraction and separation of ginkgolides A, B, C, J, M and bilobalide
CN102627656A
Preparation method of ginko biloba extract
CN104095889A
